1. Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non‐germinal centre B‐cell‐like diffuse large B‐cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial. Issue 4 (30th August 2022) Authors: Zhu, Jun; Hong, Xiaonan; Song, Yu Qin; Hodkinson, Brendan; Balasubramanian, Sriram; Wang, Songbai; Zhang, Qingyuan; Shi, Yuankai; Huang, Huiqiang; Zhang, Huilai; Zhu, Yan; Shreeve, Stephen Martin; Sun, Steven; Wang, Ze; Wang, Xiaocan; Fan, Yue; Wilson, Wyndham; Vermeulen, Jessica Journal: EJHaem Issue: Volume 3:Issue 4(2022) Page Start: 1154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗